
Although both type 1 and type 2 diabetes lead to elevated blood glucose levels, the treatment approach is not the same because the underlying disease mechanisms are different. In type 1 diabetes, there is an absolute insulin deficiency caused by autoimmune destruction of pancreatic beta cells, while type 2 is primarily characterized by insulin resistance and a gradual decline in the pancreas's ability to maintain adequate insulin secretion. As a result, the start of treatment, medication choices, intensity of monitoring and day-to-day disease management differ [1], [2], [3], [4].
In type 1 diabetes, insulin is essential from the beginning, and the disease cannot be managed safely without it. Treatment is based on replacing insulin through multiple daily injections or an insulin pump, together with regular glucose monitoring [1], [4], [5], [6].
In type 2 diabetes, insulin is not always the first treatment option. Management includes lifestyle changes and medications that are selected individually according to glucose levels, body weight, risk of hypoglycemia, kidney function, cardiovascular disease and other coexisting conditions [3], [4], [7].
In type 1 diabetes, the goal is to replace natural insulin secretion as closely as possible and keep glucose within an individually agreed target range. This involves matching basal and mealtime insulin with carbohydrate intake, physical activity, illness, stress and correction doses [1], [4].
Day-to-day self-management is intensive. A person often makes multiple treatment decisions throughout the day, so education about insulin, carbohydrate counting, hypoglycemia, hyperglycemia and sick-day rules is an important part of therapy [1], [4], [8].
In type 2 diabetes, the approach extends beyond lowering glucose alone. In addition to glycemia, body weight, blood pressure, lipids, cardiovascular risk and kidney function should be assessed because these factors are often interconnected [4], [7].
Treatment is therefore individualized. For some people, the priority is reaching a target HbA1c; for others, it is weight reduction. In people with atherosclerotic cardiovascular disease, heart failure or chronic kidney disease, protecting the heart and kidneys can also be an important part of treatment selection [4], [7].
Diet and physical activity are important in both type 1 and type 2 diabetes, but their practical role is not identical. In type 1 diabetes, food intake is coordinated with insulin and physical activity to reduce large glucose fluctuations. In type 2 diabetes, lifestyle changes can contribute to better glycemic control, weight reduction and lower cardiometabolic risk [1], [3], [4].
It is important to understand that lifestyle changes cannot replace insulin in type 1 diabetes. In type 2 diabetes, especially in earlier stages, they can have a major clinical effect, although the need for medication depends on the individual situation [1], [3], [4].
In type 1 diabetes, glucose monitoring is usually more intensive. Continuous glucose monitoring (CGM) allows glucose values and trends to be followed throughout the day and night, and NIDDK and ADA describe it as an important tool in modern type 1 diabetes management [5], [6].
In type 2 diabetes, the frequency of self-monitoring depends on treatment, hypoglycemia risk and individual goals. People using insulin or therapies associated with a higher risk of hypoglycemia may require more frequent monitoring, while other treatment regimens may require a less intensive approach [4], [6], [8].
In type 1 diabetes, special attention is given to hypoglycemia and diabetic ketoacidosis (DKA), because both can develop quickly and require timely recognition and action. Structured education about prevention, symptoms and management of hypoglycemia and hyperglycemic crises is an important part of care [8].
In type 2 diabetes, there is also a strong focus on long-term cardiometabolic risk. Blood pressure, lipids, body weight and kidney function, as well as the use of medications with proven cardiovascular or kidney benefits, may all be part of the treatment plan [4], [7].
Type 1 diabetes cannot be treated without insulin. Diet, physical activity, education and technology can significantly improve disease management, but they cannot replace insulin therapy [1], [5], [6].
Type 2 diabetes is not managed only through blood glucose levels. Modern care also considers body weight, cardiovascular risk, kidney function and coexisting conditions, so treatment must be individualized [4], [7].
Glucose monitoring, treatment selection and therapeutic goals differ between type 1 and type 2 diabetes, but in both cases they should be adapted to the needs of the individual person [1], [3], [4], [6].
[1] National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Type 1 Diabetes. Accessed 2026.
https://www.niddk.nih.gov/health-information/diabetes/overview/what-is-diabetes/type-1-diabetes
[2] American Diabetes Association Professional Practice Committee for Diabetes. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes - 2026. 2026.
https://pmc.ncbi.nlm.nih.gov/articles/PMC12690183/
[3] Centers for Disease Control and Prevention (CDC). Type 2 Diabetes. 2024.
https://www.cdc.gov/diabetes/about/about-type-2-diabetes.html
[4] American Diabetes Association Professional Practice Committee for Diabetes. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes - 2026. 2026.
https://pmc.ncbi.nlm.nih.gov/articles/PMC12690185/
[5] National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Continuous Glucose Monitoring. Accessed 2026.
[6] American Diabetes Association Professional Practice Committee for Diabetes. Diabetes Technology: Standards of Care in Diabetes - 2026. 2026.
https://pmc.ncbi.nlm.nih.gov/articles/PMC12690173/
[7] American Diabetes Association Professional Practice Committee for Diabetes. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes - 2026. 2026.
https://pmc.ncbi.nlm.nih.gov/articles/PMC12690187/
[8] American Diabetes Association Professional Practice Committee for Diabetes. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes - 2026. 2026.
https://pmc.ncbi.nlm.nih.gov/articles/PMC12690178/
Health Disclaimer: This content is for educational and informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before starting or changing any supplement, especially if you are pregnant, breastfeeding, have a medical condition, or take medication.